So, here's today's pitch from the dugout: a change-up.
Eisai, like the White Sox, hires HH (WS signs Alonso and Jay) in an effort to attract Anavex/Missling (Machado) to join its team ... and like, the White Sox (Machado signed with Padres), IMO, it will fail to work.
Missling gleefully agreed to the Consortium with Merck, Takada et al on the basis of its interest in advancing medicine and drug development into the 2020's with a group of companies that span the world and understand how to work together, unlike some other companies.
Eisai's insistence on continuing 1) the AB/Tau work 2) with Biogen gives them those 2 strikes against it before it even comes to bat. The Pfizer connection is considered a foul ball on Pitch 3.
The Consortium allows Anavex/Missling to move forward with the development of the pipeline with some security, probably providing some resources to move the necessary testing of the pipeline at an accelerated pace more so if there were no consortium.
IMO, TGD and Anavex will continue to be an independent company for several more years unless the pipeline proves to be a bust, which I don't believe will happen based on reading the posts of folks like falconer, Xena, georgejj, the real Bio, sokol, Mc, Ziggy, Bourbon and to our probably late patent expert, ipman.
ANAVEX NOW ... MONO-STYLE ... RWEm for Life!!!
Market Data 
Markets 
